Predictors of response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension
A. Garcia (Madrid, Spain), I. Blanco (Madrid, Spain), R. Borras (Barcelona, Spain), M. Lopez-Meseguer (Barcelona, Spain), J. Domingo-Morera (Zaragoza, Spain), C. Martin-Ontiyuelo (Madrid, Spain), O. Tura (Madrid, Spain), I. Otero-Gonzalez (A Coruña, Spain), P. Escribano-Subías (Madrid, Spain), J. Barberà (Madrid, Spain)
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Session: Therapy of pulmonary hypertension
Session type: E-poster
Number: 1921
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Garcia (Madrid, Spain), I. Blanco (Madrid, Spain), R. Borras (Barcelona, Spain), M. Lopez-Meseguer (Barcelona, Spain), J. Domingo-Morera (Zaragoza, Spain), C. Martin-Ontiyuelo (Madrid, Spain), O. Tura (Madrid, Spain), I. Otero-Gonzalez (A Coruña, Spain), P. Escribano-Subías (Madrid, Spain), J. Barberà (Madrid, Spain). Predictors of response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension. 1921
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: